Literature DB >> 8005600

Molecular defects in erythropoietic protoporphyria with terminal liver failure.

X Schneider-Yin1, B W Schäfer, P Möhr, G Burg, E I Minder.   

Abstract

We identified two additional mutations in the ferrochelatase gene in two Swiss patients with erythropoietic protoporphyria (EPP). Ferrochelatase cDNA from patients was amplified by the polymerase chain reaction (PCR) and subjected to mutation analysis by sequencing PCR products either directly or after subcloning. The first patient, who underwent liver transplantation because of terminal liver failure, was identified as having a single point mutation (C to T) at nucleotide 175 that resulted in a Gln to stop codon conversion in one allele of the gene. In the second case, in which the patient has so far no liver involvement, a two-base deletion (T899G900) was found in one allele. Frameshift as a result of the deletion creates a stop codon. This study presents two new genotypes of EPP, including one with liver failure, a rare and fatal form of EPP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005600     DOI: 10.1007/BF00201578

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase.

Authors:  Y Nakahashi; S Taketani; M Okuda; K Inoue; R Tokunaga
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

2.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.

Authors:  Y Nakahashi; H Fujita; S Taketani; N Ishida; A Kappas; S Sassa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Ferrochelatase activity in human lymphocytes, as quantified by a new high-performance liquid-chromatographic method.

Authors:  E Rossi; K A Costin; P Garcia-Webb
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

4.  A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing.

Authors:  X Wang; M Poh-Fitzpatrick; D Carriero; L Ostasiewicz; T Chen; S Taketani; S Piomelli
Journal:  Biochim Biophys Acta       Date:  1993-04-30

5.  Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene.

Authors:  Y Nakahashi; H Miyazaki; Y Kadota; Y Naitoh; K Inoue; M Yamamoto; N Hayashi; S Taketani
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  Cytofluorometry as a diagnosis of protoporphyria.

Authors:  B E Schleiffenbaum; E I Minder; P Möhr; M Decurtins; A Schaffner
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

7.  A molecular defect in human protoporphyria.

Authors:  D A Brenner; J M Didier; F Frasier; S R Christensen; G A Evans; H A Dailey
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

8.  Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene.

Authors:  J Lamoril; S Boulechfar; H de Verneuil; B Grandchamp; Y Nordmann; J C Deybach
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

9.  Genetic aspects of erythropoietic protoporphyria.

Authors:  L N Went; E C Klasen
Journal:  Ann Hum Genet       Date:  1984-05       Impact factor: 1.670

10.  Molecular defect in human erythropoietic protoporphyria with fatal liver failure.

Authors:  Y Nakahashi; H Miyazaki; Y Kadota; Y Naitoh; K Inoue; M Yamamoto; N Hayashi; S Taketani
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

View more
  7 in total

1.  Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.

Authors:  U B Rüfenacht; L Gouya; X Schneider-Yin; H Puy; B W Schäfer; R Aquaron; Y Nordmann; E I Minder; J C Deybach
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 3.  Erythropoietic protoporphyria.

Authors:  T M Cox
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 4.  Theodore Woodward Award. Pathogenesis of biochemical abnormalities in protoporphyria.

Authors:  J R Bloomer; M B Poh-Fitzpatrick
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 5.  The ferrochelatase gene structure and molecular defects associated with erythropoietic protoporphyria.

Authors:  S Taketani; H Fujita
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

6.  Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing.

Authors:  X Schneider-Yin; B W Schäfer; O Tönz; E I Minder
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

7.  Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.

Authors:  Giovanni Genovese; Carlo Alberto Maronese; Chiara Moltrasio; Roberta Piccinno; Dario Antonio Marletta; Giacomo De Luca; Giovanna Graziadei; Francesca Granata; Elena Di Pierro; Maria Domenica Cappellini; Angelo Valerio Marzano
Journal:  Photodermatol Photoimmunol Photomed       Date:  2021-08-30       Impact factor: 3.254

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.